PFIZER INC — Director's Dealing 2012

Feb 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2012-02-23

Reporting Person: SUSMAN SALLY (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-23	Common Stock	A	22385.0000	$0.0000	Acquired	230191.0000	Direct
2012-02-24	Common Stock	A	30309.0000	$0.0000	Acquired	260500.0000	Direct
2012-02-24	Common Stock	F	15298.0000	$21.1800	Disposed	245202.0000	Direct
2012-02-24	Common Stock	F	24809.0000	$21.1800	Disposed	220393.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-23	Stock Appreciation Rights	$21.0300	A	115291.0000	Acquired	2017-02-23	Common Stock (115291.0000)	Direct
2012-02-23	Stock Appreciation Rights	$21.0300	A	97737.0000	Acquired	2019-02-23	Common Stock (97737.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2732.0000	Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.

F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).

F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).

F4: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

F5: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F6: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.